Table 3

HR of p53 mutation positive versus negative patients with advanced NSCLC by Cox regression analysisa

PopulationHazards ratioP95% CI
All patients (n = 70)3.43<0.0011.99–5.88
Patients received chemotherapy (n = 39)3.250.0021.55–6.97
Patients received supportive care only (n = 31)4.240.0181.36–15.5
  • a Variables used were age, sex, serum LDH level, performance status, clinical stage, histological type, body weight loss, and p53 mutation.